(Q35893656)

11 August 2017

1 reference

title

Tolerance induction in clinical transplantation (English)

1 reference

11 August 2017

Thomas Fehr

1

1 reference

11 August 2017

Megan Sykes

series ordinal

2

1 reference

11 August 2017

publication date

1 September 2004

1 reference

11 August 2017

published in

Transplant Immunology

1 reference

11 August 2017

volume

13

1 reference

11 August 2017

issue

2

1 reference

11 August 2017

page(s)

117-130

1 reference

Kidney transplantation between seven pairs of identical twins

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.009

COMBINED IMMUNOSUPPRESSIVE ACTION OF PHYTOHAEMAGGLUTININ AND AZATHIOPRINE (IMURAN) ON DOGS WITH RENAL HOMOTRANSPLANTS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.009

Strategies to improve long-term outcomes after renal transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.009

Tolerance and chronic rejection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.009

Intra-bone marrow injection of allogeneic bone marrow cells: a powerful new strategy for treatment of intractable autoimmune diseases in MRL/lpr mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.009

Treatment of severe systemic lupus erythematosus with high-dose chemotherapy and haemopoietic stem-cell transplantation: a phase I study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.009

Mixed hematopoietic chimerism allows cure of autoimmune diabetes through allogeneic tolerance and reversal of autoimmunity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.009

Bone marrow transplantation attenuates murine IgA nephropathy: role of a stem cell disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.009

Evidence that improved late renal transplant outcome correlates with the development of in vitro donor antigen-specific hyporeactivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.009

Indirect allorecognition of major histocompatibility complex allopeptides in human renal transplant recipients with chronic graft dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.009

Persistent allopeptide reactivity and epitope spreading in chronic rejection of organ allografts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.009

Indirect recognition of donor HLA class I peptides in lung transplant recipients with bronchiolitis obliterans syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.009

Indirect allorecognition of mismatched donor HLA class II peptides in lung transplant recipients with bronchiolitis obliterans syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.009

Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.009

STEALTH matters: a novel paradigm of durable primate allograft tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.009

Quantifying the frequency of alloreactive T cells in vivo: new answers to an old question

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.009

Evidence for thymic function in the elderly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.009

Intrathymic deletion of alloreactive T cells in mixed bone marrow chimeras prepared with a nonmyeloablative conditioning regimen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.009

Cellular basis of long-term organ transplant acceptance: pivotal role of intrathymic clonal deletion and thymic dependence of bone marrow microchimerism-associated tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.009

Mixed chimerism and transplant tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.009

Mixed chimerism and permanent specific transplantation tolerance induced by a nonlethal preparative regimen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.009

Additional monoclonal antibody (mAB) injections can replace thymic irradiation to allow induction of mixed chimerism and tolerance in mice receiving bone marrow transplantation after conditioning with anti-T cell mABs and 3-Gy whole body irradiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.009

Induction of tolerance by mixed chimerism with nonmyeloblative host conditioning: the importance of overcoming intrathymic alloresistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.009

Anti-CD154 or CTLA4Ig obviates the need for thymic irradiation in a non-myeloablative conditioning regimen for the induction of mixed hematopoietic chimerism and tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.009

Extrathymic T cell deletion and allogeneic stem cell engraftment induced with costimulatory blockade is followed by central T cell tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.009

Peripheral deletion after bone marrow transplantation with costimulatory blockade has features of both activation-induced cell death and passive cell death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.009

Lack of role for CsA-sensitive or Fas pathways in the tolerization of CD4 T cells via BMT and anti-CD40L.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.009

Thymic dependence of loss of tolerance in mixed allogeneic bone marrow chimeras after depletion of donor antigen. Peripheral mechanisms do not contribute to maintenance of tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.009

A Theory of Self-Nonself Discrimination: Paralysis and induction involve the recognition of one and two determinants on an antigen, respectively

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.009

A cell culture model for T lymphocyte clonal anergy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.009

The complementary roles of deletion and regulation in transplantation tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.009

Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.009

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.009

inferred from DOI database lookup

7 January 2021

based on heuristic

Allogeneic bone marrow transplantation with co-stimulatory blockade induces macrochimerism and tolerance without cytoreductive host treatment

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.009

Mechanisms of early peripheral CD4 T-cell tolerance induction by anti-CD154 monoclonal antibody and allogeneic bone marrow transplantation: evidence for anergy and deletion but not regulatory cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.009

Mixed chimerism and transplantation tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.009

Immunobiology of tissue transplantation: a return to the passenger leukocyte concept

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.009

Transplantation tolerance from a historical perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.009

Complete protection of islets against allorejection and autoimmunity by a simple barium-alginate membrane

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.009

The abrogation of allosensitization following the induction of mixed allogeneic chimerism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.009

Tolerization of Gal alpha 1,3Gal-reactive B cells in pre-sensitized alpha 1,3-galactosyltransferase-deficient mice by nonmyeloablative induction of mixed chimerism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.009

Heterologous immunity: an overlooked barrier to tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.009

Homeostatic proliferation is a barrier to transplantation tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.009

Homeostatic T cell proliferation: how far can T cells be activated to self-ligands?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.009

Mechanisms of tolerance to rat heart allografts using posttransplant TLI. Changes in cytokine expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.009

Transplantation tolerance in primates following total lymphoid irradiation and allogeneic bone marrow injection. II. Renal allografts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.009

Transplantation tolerance in primates after total lymphoid irradiation and allogeneic bone marrow injection. III. Lymphocyte responsiveness and suppressor cell activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.009

Tolerance in baboon kidney transplantation with total lymphoid irradiation (TLI) and anti-CD3/CD4-idarubicin conjugates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.009

Acquired immune tolerance to cadaveric renal allografts. A study of three patients treated with total lymphoid irradiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.009

Clinical transplantation tolerance twelve years after prospective withdrawal of immunosuppressive drugs: studies of chimerism and anti-donor reactivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.009

FN18-CRM9 immunotoxin promotes tolerance in primate renal allografts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.009

Preclinical studies of allograft tolerance in rhesus monkeys: a novel anti-CD3-immunotoxin given peritransplant with donor bone marrow induces operational tolerance to kidney allografts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.009

Analysis of primate renal allografts after T-cell depletion with anti-CD3-CRM9.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.009

Split tolerance induced by immunotoxin in a rhesus kidney allograft model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.009

The future of organ transplantation: from the laboratory to the clinic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.009

Prope tolerance, perioperative campath 1H, and low-dose cyclosporin monotherapy in renal allograft recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.009

CAMPATH IH ALLOWS LOW-DOSE CYCLOSPORINE MONOTHERAPY IN 31 CADAVERIC RENAL ALLOGRAFT RECIPIENTS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.009

Results from a human renal allograft tolerance trial evaluating the humanized CD52-specific monoclonal antibody alemtuzumab (CAMPATH-1H).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.009

Peritransplant tolerance induction with anti-CD3-immunotoxin: a matter of proinflammatory cytokine control.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.009

Peritransplant tolerance induction in macaques: early events reflecting the unique synergy between immunotoxin and deoxyspergualin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.009

Durable donor-specific T and B cell tolerance in rhesus macaques induced with peritransplantation anti-CD3 immunotoxin and deoxyspergualin: absence of chronic allograft nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.009

RETRACTED: Tolerance induced by anti-CD3 immunotoxin plus 15-deoxyspergualin associates with donor-specific indirect pathway unresponsiveness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.009

Long-term kidney graft survival by delayed T cell ablative treatment in rhesus monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.009

Campath-1H induction plus rapamycin monotherapy for renal transplantation: results of a pilot study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.009

CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.009

Induction therapy with monoclonal antibodies specific for CD80 and CD86 delays the onset of acute renal allograft rejection in non-human primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.009

Long-term survival and function of intrahepatic islet allografts in rhesus monkeys treated with humanized anti-CD154.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.009

Prolongation of primate cardiac allograft survival by treatment with ANTI-CD40 ligand (CD154) antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.009

Anti-CD40 therapy extends renal allograft survival in rhesus macaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.009

Tolerance and near-tolerance strategies in monkeys and their application to human renal transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.009

Pretransplant blood transfusion without additional immunotherapy generates CD25+CD4+ regulatory T cells: a potential explanation for the blood-transfusion effect

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.009

Donor-specific transfusion and donor bone marrow infusion in renal transplantation tolerance: a review of efficacy and mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.009

Pretransplantation blood transfusion revisited

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.009

Peripheral blood microchimerism in human liver and renal transplant recipients: rejection despite donor-specific chimerism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.009

Prospective evaluation of pretransplant blood transfusions in cadaver kidney recipients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.009

Evaluation of pre- and posttransplant donor-specific transfusion/cyclosporine A in non-HLA identical living donor kidney transplant recipients. Cooperative Clinical Trials in Transplantation Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.009

Treatment with the humanized CD154-specific monoclonal antibody, hu5C8, prevents acute rejection of primary skin allografts in nonhuman primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.009

Blockade of CD40-CD154 at the time of donor-specific blood transfusion does not lead to prolonged kidney allograft survival in nonhuman primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.009

Immunologic tolerance to renal allografts after bone marrow transplants from the same donors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.009

Renal transplantation for end-stage renal disease following bone marrow transplantation: a report of six cases, with and without immunosuppression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.009

Tolerance in renal transplantation after allogeneic bone marrow transplantation-6-year follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.009

Outcomes of renal transplantation following bone marrow transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.009

Transplantation of a lobe of lung from mother to child following previous transplantation with maternal bone marrow

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.009

Living donor liver transplantation and tolerance: a potential strategy in cholangiocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.009

Discontinuation of immunosuppression for prevention of kidney graft rejection after receiving a bone marrow transplant from the same HLA identical sibling donor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.009

Transplantation of autologous and allogeneic bone marrow with liver from a cadaveric donor for primary liver cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.009

Modifications of the conditioning regimen for achieving mixed chimerism and donor-specific tolerance in cynomolgus monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.009

Mixed chimerism and transplantation tolerance induced by a nonlethal preparative regimen in cynomolgus monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.009

Long-term outcome and alloantibody production in a non-myeloablative regimen for induction of renal allograft tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.009

Effect of mixed hematopoietic chimerism on cardiac allograft survival in cynomolgus monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.009

Thromboembolic complications after treatment with monoclonal antibody against CD40 ligand

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.009

Thrombophilia associated with anti-CD154 monoclonal antibody treatment and its prophylaxis in nonhuman primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.009

Long-term results of a controlled prospective study with transfusion of donor-specific bone marrow in 57 cadaveric renal allograft recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.009

Simultaneous administration of adjuvant donor bone marrow in pancreas transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.009

Megadose approach to DBMC infusion-induced allograft hyporesponsiveness in living-related renal allograft recipients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.009

High-dose donor bone marrow infusions to enhance allograft survival: the effect of timing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.009

Evidence for the presence of multilineage chimerism and progenitors of donor dendritic cells in the peripheral blood of bone marrow-augmented organ transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.009

Mixed chimerism and immunosuppressive drug withdrawal after HLA-mismatched kidney and hematopoietic progenitor transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.009

Approaches to transplantation tolerance in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.009

Lymphohematopoietic graft-vs.-host reactions can be induced without graft-vs.-host disease in murine mixed chimeras established with a cyclophosphamide-based nonmyeloablative conditioning regimen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.009

Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.009

Intentional induction of mixed chimerism and achievement of antitumor responses after nonmyeloablative conditioning therapy and HLA-matched donor bone marrow transplantation for refractory hematologic malignancies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.009

Mixed lymphohaemopoietic chimerism and graft-versus-lymphoma effects after non-myeloablative therapy and HLA-mismatched bone-marrow transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.009

Combined histocompatibility leukocyte antigen-matched donor bone marrow and renal transplantation for multiple myeloma with end stage renal disease: the induction of allograft tolerance through mixed lymphohematopoietic chimerism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.009

Induction of kidney allograft tolerance after transient lymphohematopoietic chimerism in patients with multiple myeloma and end-stage renal disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.009

SELECTIVE DELETION OF ANTIGEN-SPECIFIC, ACTIVATED T CELLS BY A HUMANIZED MAB TO CD2 (MEDI-507) IS MEDIATED BY NK CELLS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.009

Nonmyeloablative haploidentical stem-cell transplantation using anti-CD2 monoclonal antibody (MEDI-507)-based conditioning for refractory hematologic malignancies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.009

IMMUNOGENETIC CONSEQUENCES OF VASCULAR ANASTOMOSES BETWEEN BOVINE TWINS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.009

Infusion of donor leukocytes to induce tolerance in organ allograft recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.009

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.TRIM.2004.05.009

1 reference

11 August 2017

1 reference